238 related articles for article (PubMed ID: 17643878)
1. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
[TBL] [Abstract][Full Text] [Related]
4. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
Barakat NS; Shazly GA; Almedany AH
Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
[TBL] [Abstract][Full Text] [Related]
5. Composite microparticles with in vivo reduction of the burst release effect.
Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
[TBL] [Abstract][Full Text] [Related]
6. Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.
Pignatello R; Musumeci T; Impallomeni G; Carnemolla GM; Puglisi G; Ballistreri A
Eur J Pharm Sci; 2009 Jun; 37(3-4):451-62. PubMed ID: 19504659
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of heparin-loaded polymeric microparticles.
Jiao YY; Ubrich N; Hoffart V; Marchand-Arvier M; Vigneron C; Hoffman M; Maincent P
Drug Dev Ind Pharm; 2002 Sep; 28(8):1033-41. PubMed ID: 12378958
[TBL] [Abstract][Full Text] [Related]
8. A burst drug release caused by imperfection of polymeric film-coated microparticles prepared by a fluidized bed coater.
Sriamornsak P; Casallas-Hernández GL; Manchun S; Kumpugdee-Vollrath M
Pharmazie; 2011 Aug; 66(8):576-83. PubMed ID: 21901979
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
Huang J; Wigent RJ; Schwartz JB
Drug Dev Ind Pharm; 2006; 32(10):1185-97. PubMed ID: 17090441
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
11. Microparticles prepared by grinding of polymeric films.
Elkharraz K; Dashevsky A; Bodmeier R
J Microencapsul; 2003; 20(5):661-73. PubMed ID: 12909549
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of gelatin and ethylcellulose microparticles designed as platforms to delivery fluoride.
de Francisco LM; Cerquetani JA; Bruschi ML
Drug Dev Ind Pharm; 2013 Nov; 39(11):1644-50. PubMed ID: 23034061
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics.
Hoffart V; Ubrich N; Simonin C; Babak V; Vigneron C; Hoffman M; Lecompte T; Maincent P
Drug Dev Ind Pharm; 2002 Oct; 28(9):1091-9. PubMed ID: 12455468
[TBL] [Abstract][Full Text] [Related]
14. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery. Effect of drug loading on release kinetics.
Huang J; Wigent RJ; Bentzley CM; Schwartz JB
Int J Pharm; 2006 Aug; 319(1-2):44-54. PubMed ID: 16678366
[TBL] [Abstract][Full Text] [Related]
16. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium.
Balzus B; Sahle FF; Hönzke S; Gerecke C; Schumacher F; Hedtrich S; Kleuser B; Bodmeier R
Eur J Pharm Biopharm; 2017 Jun; 115():122-130. PubMed ID: 28189623
[TBL] [Abstract][Full Text] [Related]
17. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
19. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
20. Oil-in-oil microencapsulation technique with an external perfluorohexane phase.
Mana Z; Pellequer Y; Lamprecht A
Int J Pharm; 2007 Jun; 338(1-2):231-7. PubMed ID: 17368983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
